Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NEVIRAPINE TABLETS safely and effectively. See full prescribing information for NEVIRAPINE TABLETS. NEVIRAPINE tablets, for oral use Initial U.S. Approval: 1996
Medication labelWhy this: Advisory · dailymed-prescription
Nevirapine tablet is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adults and pediatric patients 15 days and older [see Clinical Studies (14.1, 14.2)] . Limitations of Use: Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, nevirapine tablet is not recommended to be initiated, unless the benefit outweighs the risk, in: adult females with CD4 +cell counts greater than 250 cells/mm 3or adult males with CD4 +cell counts greater than 400 cells/mm 3 [see Warnings and Precautions (5.1)] .
- generic_name
- nevirapine
- product_names
- NEVIRAPINE
- ndc
- 42571-131, 42571-131-60, 42571-131-29
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en